Usefulness of the SAMe-TT2R2 risk score in identifying patients who will do well with vitamin K antagonist therapy in a community-based cohort of patients with non-valvular atrial fibrillation
Data de publicación
2014Título da revista
European Heart Journal
Tipo de contido
Publicación de congreso